Evidence map›Paper›PMID 42729749›Full record

ReviewFrontiers in cell and developmental biology2026

Molecular mechanisms and translational potential of plant-derived nanovesicles in skin care and regeneration.

Lele Wang, Xiang Li, Mengke Sheng, Yue Li, Shaobo Liu, JiaYing Wu, Hu Huang, Hang Fan

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lele Wang *Henan Academy of Sciences, Zhenzhou, China.
Xiang Li *Proya Cosmetics Co., Ltd, Hangzhou, China.
Mengke ShengHenan High-tech Industrial Co., Ltd., Zhenzhou, China.
Yue LiProya Cosmetics Co., Ltd, Hangzhou, China.
Shaobo LiuHenan Academy of Sciences, Zhenzhou, China.
JiaYing WuProya Cosmetics Co., Ltd, Hangzhou, China.
Hu HuangProya Cosmetics Co., Ltd, Hangzhou, China.
Hang FanHenan Academy of Sciences, Zhenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant-derived nanovesicles (PDNVs) are emerging as a novel class of natural biomaterials with significant potential in dermatological applications, owing to their unique lipid bilayer structure, broad source availability, and low immunogenicity. This review systematically delineates the biogenesis pathways of PDNVs-including the multivesicular body (MVB) and exocyst-positive organelle (EXPO) routes-and characterizes their complex cargo, which encompasses functional proteins, regulatory microRNAs, and bioactive secondary metabolites. We critically discuss the molecular mechanisms underlying the skincare efficacy of PDNVs, emphasizing their roles in antioxidant defense via Nrf2 activation, anti-aging effects through the modulation of MMP expression and collagen synthesis, melanogenesis inhibition, and the promotion of wound healing by regulating inflammatory cytokines and the TGF-β pathway. Furthermore, the article compares PDNVs with synthetic nanocarriers and other extracellular vesicles, highlighting their superior biocompatibility and cellular uptake efficiency as natural delivery systems. Finally, we address current industrial challenges related to standardized isolation, quality control, and storage stability, and propose future perspectives on bioengineering strategies and clinical translation. This work provides a comprehensive theoretical foundation for the application of PDNVs in precision dermatology and cosmetic biotechnology.

Indexed as

antioxidantdrug deliverynanocarrierplant-derived nanovesicles (PDNVs)skin care

Identifiers

PMID42729749
PMCPMC13562905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.